ANTIBODY LEVELS ACHIEVED IN INFANTS BY COURSE OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE/DIPHTHERIA TOXOID CONJUGATE VACCINE
- 1 May 1985
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 325 (8439), 1184-1186
- https://doi.org/10.1016/s0140-6736(85)92863-6
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Safety and immunogenicity of haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of ageThe Journal of Pediatrics, 1985
- Immunogenicity of Haemophilus influenzae type b polysaccharide—diphtheria toxoid conjugate vaccine in adultsThe Journal of Pediatrics, 1984
- Prevention ofHemophilus influenzaeType B Bacteremic Infections with the Capsular Polysaccharide VaccineNew England Journal of Medicine, 1984
- Systemic Haemophilus influenzae Infection in FinlandClinical Pediatrics, 1984
- Incidence and prognosis of Haemophilus influenzae meningitis in children in a Swedish regionThe Pediatric Infectious Disease Journal, 1984
- HAEMOPHILUS INFLUENZAE DISEASE IN ALASKAN ESKIMOS: CHARACTERISTICS OF A POPULATION WITH AN UNUSUAL INCIDENCE OF INVASIVE DISEASEThe Lancet, 1981
- Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicolThe Journal of Pediatrics, 1980
- Haemophilus influenzaeMeningitisNew England Journal of Medicine, 1979
- AMPICILLIN-RESISTANT HÆMOPHILUS INFLUENZÆThe Lancet, 1974
- Immunization of Humans with Polyribophosphate, the Capsular Antigen of Hemophilus influenzae, Type bJournal of Clinical Investigation, 1972